Natalie Ward

Natalie Ward is currently the Senior Director of Regulatory Affairs CMC at Adaptimmune. Prior to this role, Natalie held positions at companies such as BioMarin Pharmaceutical Inc., Cell and Gene Therapy Catapult, and GlaxoSmithKline, where Natalie gained extensive experience in regulatory affairs for various gene therapy products and ATMPs. Natalie's academic background includes a Ph.D. from UCL in Lentiviral Vectors for the Treatment of Hemophilia, showcasing their expertise in the field.